Franklin Cockerill has spent the majority of his illustrious career associated in some way with Mayo Clinic in Rochester, Minnesota. With Mayo Clinic he served as a Clinical Microbiologist, has been the Chair of the Department of Laboratory Medicine and Pathology and has been the CEO and President of Mayo Collaborative Services, an organization that is the largest for-profit company in association with Mayo Clinical.
Franklin Cockerill spent many of the early years of his career focused on the study of infectious diseases. The change of professional focus to clinical microbiology is recent. Cockerill imagines himself someday moving to a leadership position with a small startup company in biotechnology, a senior position in a large diagnostics or laboratory testing company.
One of Franklin Cockerill’s greatest contributions to medicine came in 2001. Cockerill headed a team at the Mayo Clinic whose goal was to develop a rapid and easily performed test for the diagnosis of anthrax. After the airline terrorism events of September 11th against the United States, an outbreak of anthrax wreaked fear among US residents, especially on the East Coast. Cockerill and his team were focused on finding a way to accurately and rapidly diagnose anthrax in order to ensure expedient treatment for infected individuals. High mortality occurs in patients infected with anthrax, if they do not receive the appropriate treatment in a timely fashion. The team successfully created the test, making it possible to identify the presence of anthrax in less than one hour. The test became readily available to testing laboratories across the country.